alexa Next Generation Sequencing-Current Status
ISSN 2469-9853

Journal of Next Generation Sequencing & Applications
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Next Generation Sequencing-Current Status

Suma J1 and Sivakumar G2*

1New York Genome Center, New York, USA

2Qassim University, College of Applied Medical Sciences, Buraidah, Kingdom of Saudi Arabia

*Corresponding Author:
Sivakumar Gowder
Qassim University
College of Applied Medical Sciences
Buraidah, Kingdom of Saudi Arabia
Tel: +966566873969
Fax: +96663802268
E-mail: [email protected]

Rec date: Jan 25, 2016; Acc date: Jan 26, 2016; Pub date: Jan 29, 2016

Citation: Suma J, Sivakumar G (2016) Next Generation Sequencing-Current Status. Next Generat Sequenc & Applic 3:e107. doi: 0.4172/2469-9853.3-e107

Copyright: © 2016 Suma J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Next Generation Sequencing (NGS) is revolutionizing the study of “omics” (e.g., genomics, transcriptomics, methylomics, etc). The sequencing cost has gone down tremendously and thereby allowing most of the methods to deviate from microarrays and traditional Sanger sequencing. Illumina has the highest market share in NGS followed by Thermofisher Scientific, Roche and Pacific Biosciences. They currently sell the following instruments: HiSeqX series, HiSeq series, MiSeq, NextSeq and MiniSeq. With the arrival of HiSeqX, Illumina projects that the cost per Gigabase has gone down from $100,000,000 in the year 2000 to $1-10 in year 2014. Read-length, run time bacterial genome sequencing and maximum throughput on different platforms is reviewed in Van Djik et al., and the number of applications that can be performed using NGS is increasing every day. They can be categorized into three areas as described below.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords